1-11 of 11
Glenn M. Chertow
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Overall Adverse Event Profile of Vadadustat versus Darbepoetin Alfa for the Treatment of Anemia Associated with Chronic Kidney Disease in Phase 3 Trials

Subject Area:
Nephrology
Rajiv Agarwal, Sanjeev Anand, Kai-Uwe Eckardt, Wenli Luo, Patrick S. Parfrey, Mark J. Sarnak, Christine M. Solinsky, Dennis L. Vargo, Wolfgang C. Winkelmayer, Glenn M. Chertow
Journal: American Journal of Nephrology
Am J Nephrol (2022) 53 (10): 701–710.
https://doi.org/10.1159/000528443
Published Online: 31 January 2023
View article titled, Overall Adverse Event Profile of Vadadustat versus Darbepoetin Alfa for the Treatment of Anemia Associated with Chronic Kidney Disease in Phase 3 Trials
Open the PDF for Overall Adverse Event Profile of Vadadustat versus Darbepoetin Alfa for the Treatment of Anemia Associated with Chronic Kidney Disease in Phase 3 Trials in another window
Journal Articles

Study Design and Baseline Characteristics of the CARDINAL Trial: A Phase 3 Study of Bardoxolone Methyl in Patients with Alport Syndrome

Subject Area:
Nephrology
Glenn M. Chertow, Gerald B. Appel, Sharon Andreoli, Sripal Bangalore, Geoffrey A. Block, Arlene B. Chapman, Melanie P. Chin, Keisha L. Gibson, Angie Goldsberry, Kazumoto Iijima, Lesley A. Inker, Bertrand Knebelmann, Laura H. Mariani, Colin J. Meyer, Kandai Nozu, Megan O’Grady, Arnold L. Silva, Peter Stenvinkel, Roser Torra, Bradley A. Warady, Pablo E. Pergola
Journal: American Journal of Nephrology
Am J Nephrol (2021) 52 (3): 180–189.
https://doi.org/10.1159/000513777
Published Online: 31 March 2021
View article titled, Study Design and Baseline Characteristics of the CARDINAL Trial: A Phase 3 Study of Bardoxolone Methyl in Patients with Alport Syndrome
Open the PDF for Study Design and Baseline Characteristics of the CARDINAL Trial: A Phase 3 Study of Bardoxolone Methyl in Patients with Alport Syndrome in another window
Journal Articles

Fibroblast Growth Factor 23 Genotype and Cardiovascular Disease in Patients Undergoing Hemodialysis

Subject Area:
Nephrology
Tae-Hwi Schwantes-An, Sai Liu, Margaret Stedman, Brian S. Decker, Leah Wetherill, Howard J. Edenberg, Matteo Vatta, Tatiana M. Foroud, Glenn M. Chertow, Sharon M. Moe
Journal: American Journal of Nephrology
Am J Nephrol (2019) 49 (2): 125–132.
https://doi.org/10.1159/000496060
Published Online: 22 January 2019
View article titled, Fibroblast Growth Factor 23 Genotype and Cardiovascular Disease in Patients Undergoing Hemodialysis
Open the PDF for Fibroblast Growth Factor 23 Genotype and Cardiovascular Disease in Patients Undergoing Hemodialysis in another window
Journal Articles

Bardoxolone Methyl Improves Kidney Function in Patients with Chronic Kidney Disease Stage 4 and Type 2 Diabetes: Post-Hoc Analyses from Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes Study

Subject Area:
Nephrology
Melanie P. Chin, George L. Bakris, Geoffrey A. Block, Glenn M. Chertow, Angie Goldsberry, Lesley A. Inker, Hiddo J.L. Heerspink, Megan O’Grady, Pablo E. Pergola, Christoph Wanner, David G. Warnock, Colin J. Meyer
Journal: American Journal of Nephrology
Am J Nephrol (2018) 47 (1): 40–47.
https://doi.org/10.1159/000486398
Published Online: 18 January 2018
View article titled, Bardoxolone Methyl Improves Kidney Function in Patients with Chronic Kidney Disease Stage 4 and Type 2 Diabetes: Post-Hoc Analyses from Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes Study
Open the PDF for Bardoxolone Methyl Improves Kidney Function in Patients with Chronic Kidney Disease Stage 4 and Type 2 Diabetes: Post-Hoc Analyses from Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes Study in another window
Journal Articles

Chronic Kidney Disease Classification in Systolic Blood Pressure Intervention Trial: Comparison Using Modification of Diet in Renal Disease and CKD-Epidemiology Collaboration Definitions

Subject Area:
Nephrology
Michael V. Rocco, Arlene Chapman, Glenn M. Chertow, Debbie Cohen, Jing Chen, Jeffrey A. Cutler, Matthew J. Diamond, Barry I. Freedman, Amret Hawfield, Eric Judd, Anthony A. Killeen, Kent Kirchner, Cora E. Lewis, Nicholas M. Pajewski, Barry M. Wall, Jerry Yee, for the SPRINT Research Group
Journal: American Journal of Nephrology
Am J Nephrol (2016) 44 (2): 130–140.
https://doi.org/10.1159/000448722
Published Online: 12 August 2016
View article titled, Chronic Kidney Disease Classification in Systolic Blood Pressure Intervention Trial: Comparison Using Modification of Diet in Renal Disease and CKD-Epidemiology Collaboration Definitions
Open the PDF for Chronic Kidney Disease Classification in Systolic Blood Pressure Intervention Trial: Comparison Using Modification of Diet in Renal Disease and CKD-Epidemiology Collaboration Definitions in another window
Journal Articles

Association of Self-Reported Frailty with Falls and Fractures among Patients New to Dialysis

Subject Area:
Topic Article Package: Diabetes , Nephrology
Cynthia Delgado, Stephanie Shieh, Barbara Grimes, Glenn M. Chertow, Lorien S. Dalrymple, George A. Kaysen, John Kornak, Kirsten L. Johansen
Journal: American Journal of Nephrology
Am J Nephrol (2015) 42 (2): 134–140.
https://doi.org/10.1159/000439000
Published Online: 19 September 2015
View article titled, Association of Self-Reported Frailty with Falls and Fractures among Patients New to Dialysis
Open the PDF for Association of Self-Reported Frailty with Falls and Fractures among Patients New to Dialysis in another window
Journal Articles

Rationale and Trial Design of Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes: The Occurrence of Renal Events (BEACON)

Subject Area:
Topic Article Package: Diabetes , Nephrology
Dick de Zeeuw, Tadao Akizawa, Rajiv Agarwal, Paul Audhya, George L. Bakris, Melanie Chin, Melissa Krauth, Hiddo J. Lambers Heerspink, Colin J. Meyer, John J. McMurray, Hans-Henrik Parving, Pablo E. Pergola, Giuseppe Remuzzi, Robert D. Toto, Nosratola D. Vaziri, Christoph Wanner, David G. Warnock, Janet Wittes, Glenn M. Chertow
Journal: American Journal of Nephrology
Am J Nephrol (2013) 37 (3): 212–222.
https://doi.org/10.1159/000346948
Published Online: 28 February 2013
View article titled, Rationale and Trial Design of Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes: The Occurrence of Renal Events (BEACON)
Open the PDF for Rationale and Trial Design of Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes: The Occurrence of Renal Events (BEACON) in another window
Journal Articles

Acute Kidney Injury and Mortality in Hospitalized Patients

Subject Area:
Nephrology
Henry E. Wang, Paul Muntner, Glenn M. Chertow, David G. Warnock
Journal: American Journal of Nephrology
Am J Nephrol (2012) 35 (4): 349–355.
https://doi.org/10.1159/000337487
Published Online: 02 April 2012
View article titled, Acute Kidney Injury and Mortality in Hospitalized Patients
Open the PDF for Acute Kidney Injury and Mortality in Hospitalized Patients in another window
Journal Articles

Nutrition and the Dialysis Prescription

Subject Area:
Nephrology
Glenn M. Chertow, Alisa Bullard, Michael Lazarus
Journal: American Journal of Nephrology
Am J Nephrol (1996) 16 (1): 79–89.
https://doi.org/10.1159/000168974
Published Online: 28 October 2008
View article titled, Nutrition and the Dialysis Prescription
Open the PDF for Nutrition and the Dialysis Prescription in another window
Journal Articles

Angiotensin Receptor Blockade and Arterial Compliance in Chronic Kidney Disease: A Pilot Study

Subject Area:
Nephrology
Jay P. Garg, Renee Ellis, William J. Elliott, Nahla Hasabou, Dave Chua, Glenn M. Chertow, George L. Bakris
Journal: American Journal of Nephrology
Am J Nephrol (2005) 25 (4): 393–399.
https://doi.org/10.1159/000087211
Published Online: 18 August 2005
View article titled, Angiotensin Receptor Blockade and Arterial Compliance in Chronic Kidney Disease: A Pilot Study
Open the PDF for Angiotensin Receptor Blockade and Arterial Compliance in Chronic Kidney Disease: A Pilot Study in another window
Journal Articles

The Effects of Sevelamer and Calcium Acetate on Proxies of Atherosclerotic and Arteriosclerotic Vascular Disease in Hemodialysis Patients

Subject Area:
Nephrology
Glenn M. Chertow, Paolo Raggi, James T. McCarthy, Gerald Schulman, Jeffrey Silberzweig, Amy Kuhlik, William G. Goodman, Amy Boulay, Steven K. Burke, Robert D. Toto
Journal: American Journal of Nephrology
Am J Nephrol (2003) 23 (5): 307–314.
https://doi.org/10.1159/000072822
Published Online: 08 September 2003
View article titled, The Effects of Sevelamer and Calcium Acetate on Proxies of Atherosclerotic and Arteriosclerotic Vascular Disease in Hemodialysis Patients
Open the PDF for The Effects of Sevelamer and Calcium Acetate on Proxies of Atherosclerotic and Arteriosclerotic Vascular Disease in Hemodialysis Patients in another window